Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06469190
What this trial is testing

An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy

Who this might be right for
Nephropathy
Changhai Hospital 36
Not applicableStudy completedNCT04923789
What this trial is testing

ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 100
Early research (Phase 1)Study completedNCT05828212
What this trial is testing

Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica

Who this might be right for
Neuromyelitis Optica
Zhejiang University 9
Early research (Phase 1)Active Not RecruitingNCT05044039
What this trial is testing

Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy

Who this might be right for
Non-Hodgkin LymphomaAcute Lymphocytic Leukemia
Washington University School of Medicine 42
Very early researchUnknownNCT05085431
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome

Who this might be right for
Sjogren's SyndromeAutoimmune Diseases
Zhejiang University 9
Early research (Phase 1)Temporarily pausedNCT07340853
What this trial is testing

CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Thomas Martin, MD 30
Not applicableStudy completedNCT05826288
What this trial is testing

Oncology Care at Home for BMT and CAR-T

Who this might be right for
Leukemia
University of Colorado, Denver 11
Testing effectiveness (Phase 2)Looking for participantsNCT05869279
What this trial is testing

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

Who this might be right for
B-cell NHLCLL
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07593482
What this trial is testing

Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.

Who this might be right for
B-cell Lymphoma
Swiss Cancer Institute 92
Testing effectiveness (Phase 2)UnknownNCT06006390
What this trial is testing

CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+4 more
Chongqing Precision Biotech Co., Ltd 60
Early research (Phase 1)Ended earlyNCT04227275
What this trial is testing

CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 16
Early research (Phase 1)Looking for participantsNCT06221553
What this trial is testing

Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG

Who this might be right for
DIPG Brain TumorDiffuse Intrinsic Pontine Glioma
Chulalongkorn University 9
Not applicableNot Yet RecruitingNCT07412405
What this trial is testing

This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

Who this might be right for
Adult B-cell Acute Lymphoblastic LeukemiaFollicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)+2 more
GUSTAVO SALGUERO 12
Early research (Phase 1)Active Not RecruitingNCT03873805
What this trial is testing

PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 14
Very early researchUnknownNCT03672305
What this trial is testing

Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

Who this might be right for
Primary Hepatocellular Carcinoma
The Second Hospital of Nanjing Medical University 50
Early research (Phase 1)Looking for participantsNCT04969354
What this trial is testing

Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Immunotherapy
The Affiliated Hospital of Xuzhou Medical University 20
Early research (Phase 1)UnknownNCT05393986
What this trial is testing

Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors

Who this might be right for
Gastric AdenocarcinomaPancreatic CancerGastroesophageal Junction Adenocarcinoma
Peking University 63
Early research (Phase 1)Study completedNCT05451212
What this trial is testing

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Who this might be right for
MuSK Myasthenia Gravis
Cabaletta Bio 7
Not applicableUnknownNCT03638193
What this trial is testing

Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shenzhen BinDeBio Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT06688799
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Beijing GoBroad Hospital 18
Next Page